Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 141

1.

Uptake of botulinum neurotoxin in the intestine.

Fujinaga Y, Sugawara Y, Matsumura T.

Curr Top Microbiol Immunol. 2013;364:45-59. doi: 10.1007/978-3-642-33570-9_3. Review.

PMID:
23239348
2.

Assembly and function of the botulinum neurotoxin progenitor complex.

Gu S, Jin R.

Curr Top Microbiol Immunol. 2013;364:21-44. doi: 10.1007/978-3-642-33570-9_2. Review.

3.

Interaction of botulinum toxin with the epithelial barrier.

Fujinaga Y.

J Biomed Biotechnol. 2010;2010:974943. doi: 10.1155/2010/974943. Epub 2010 Feb 14. Review.

4.

Sialic acid-dependent binding and transcytosis of serotype D botulinum neurotoxin and toxin complex in rat intestinal epithelial cells.

Niwa K, Yoneyama T, Ito H, Taira M, Chikai T, Kouguchi H, Suzuki T, Hasegawa K, Miyata K, Inui K, Ikeda T, Watanabe T, Ohyama T.

Vet Microbiol. 2010 Mar 24;141(3-4):312-20. doi: 10.1016/j.vetmic.2009.09.008. Epub 2009 Sep 10.

PMID:
19786330
5.

The botulinum toxin complex meets E-cadherin on the way to its destination.

Sugawara Y, Fujinaga Y.

Cell Adh Migr. 2011 Jan-Feb;5(1):34-6. Epub 2011 Jan 1.

6.

Clostridium botulinum serotype D neurotoxin and toxin complex bind to bovine aortic endothelial cells via sialic acid.

Yoneyama T, Miyata K, Chikai T, Mikami A, Suzuki T, Hasegawa K, Ikeda T, Watanabe T, Ohyama T, Niwa K.

FEMS Immunol Med Microbiol. 2008 Dec;54(3):290-8. doi: 10.1111/j.1574-695X.2008.00475.x. Epub 2008 Sep 17.

7.

Involvement of sialic acid in transport of serotype C1 botulinum toxins through rat intestinal epithelial cells.

Inui K, Ito H, Miyata K, Matsuo T, Horiuchi R, Ikeda T, Watanabe T, Ohyama T, Niwa K.

J Vet Med Sci. 2010 Sep;72(9):1251-5. Epub 2010 Apr 28.

8.

Structure of a bimodular botulinum neurotoxin complex provides insights into its oral toxicity.

Lee K, Gu S, Jin L, Le TT, Cheng LW, Strotmeier J, Kruel AM, Yao G, Perry K, Rummel A, Jin R.

PLoS Pathog. 2013;9(10):e1003690. doi: 10.1371/journal.ppat.1003690. Epub 2013 Oct 10.

9.

Occurrence of Clostridium botulinum neurotoxin in chronic disease of dairy cows.

Seyboldt C, Discher S, Jordan E, Neubauer H, Jensen KC, Campe A, Kreienbrock L, Scheu T, Wichern A, Gundling F, DoDuc P, Fohler S, Abdulmawjood A, Klein G, Hoedemaker M.

Vet Microbiol. 2015 Jun 12;177(3-4):398-402. doi: 10.1016/j.vetmic.2015.03.012. Epub 2015 Mar 21.

10.

Structure-based drug discovery for botulinum neurotoxins.

Swaminathan S.

Curr Top Microbiol Immunol. 2013;364:197-218. doi: 10.1007/978-3-642-33570-9_10.

PMID:
23239355
11.

[Clostridium botulinum and botulinum neurotoxin].

Hirai Y.

Brain Nerve. 2011 Jul;63(7):755-61. Review. Japanese.

PMID:
21747146
12.

A novel subunit structure of Clostridium botulinum serotype D toxin complex with three extended arms.

Hasegawa K, Watanabe T, Suzuki T, Yamano A, Oikawa T, Sato Y, Kouguchi H, Yoneyama T, Niwa K, Ikeda T, Ohyama T.

J Biol Chem. 2007 Aug 24;282(34):24777-83. Epub 2007 Jun 20.

13.

Unique biological activity of botulinum D/C mosaic neurotoxin in murine species.

Nakamura K, Kohda T, Shibata Y, Tsukamoto K, Arimitsu H, Hayashi M, Mukamoto M, Sasakawa N, Kozaki S.

Infect Immun. 2012 Aug;80(8):2886-93. doi: 10.1128/IAI.00302-12. Epub 2012 Jun 4.

14.

Gaining ground: assays for therapeutics against botulinum neurotoxin.

Hakami RM, Ruthel G, Stahl AM, Bavari S.

Trends Microbiol. 2010 Apr;18(4):164-72. doi: 10.1016/j.tim.2010.02.001. Epub 2010 Mar 4. Review.

PMID:
20202845
15.

Persistence of Botulinum neurotoxin inactivation of nerve function.

Shoemaker CB, Oyler GA.

Curr Top Microbiol Immunol. 2013;364:179-96. doi: 10.1007/978-3-642-33570-9_9.

16.

Host-cell specificity and transcytosis of nontoxic nonhemagglutinin protein of botulinum neurotoxin serotype D.

Miyashita S, Niwa K, Watanabe T, Sagane Y.

FEMS Microbiol Lett. 2014 Aug;357(2):115-22. doi: 10.1111/1574-6968.12527. Epub 2014 Jul 28.

17.

Functional dissection of the Clostridium botulinum type B hemagglutinin complex: identification of the carbohydrate and E-cadherin binding sites.

Sugawara Y, Yutani M, Amatsu S, Matsumura T, Fujinaga Y.

PLoS One. 2014 Oct 23;9(10):e111170. doi: 10.1371/journal.pone.0111170. eCollection 2014.

18.

Synchronized chaperone function of botulinum neurotoxin domains mediates light chain translocation into neurons.

Fischer A.

Curr Top Microbiol Immunol. 2013;364:115-37. doi: 10.1007/978-3-642-33570-9_6.

PMID:
23239351
19.

Characterization of Clostridium botulinum type B neurotoxin associated with infant botulism in japan.

Kozaki S, Kamata Y, Nishiki T, Kakinuma H, Maruyama H, Takahashi H, Karasawa T, Yamakawa K, Nakamura S.

Infect Immun. 1998 Oct;66(10):4811-6.

20.

Purification and characterization of nontoxic protein complex from serotype D 4947 botulinum toxin complex.

Miyata K, Sagane Y, Inui K, Miyashita S, Suzuki T, Oguma K, Ohyama T, Niwa K, Watanabe T.

Protein J. 2012 Jun;31(5):387-92. doi: 10.1007/s10930-012-9413-x.

PMID:
22565346
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk